Why is Infinium Pharma falling/rising?

As of 15-Sep, Infinium Pharmachem Ltd is experiencing a decline in its stock price, currently at 246.00, which reflects a decrease of 4.6 or 1.84%. The stock has underperformed its sector by 1.39% today and is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Additionally, there has been a significant drop in investor participation, with delivery volume falling by 74.36% against the 5-day average. Over the past week, the stock has gained 0.37%, but it has underperformed over the past month with a decline of 2.63% and a year-to-date drop of 17.97%. No positive or negative factors were provided to further explain the stock's recent movement.
Broader market context indicates that while the Sensex has increased by 1.20% over the past week, Infinium Pharma's performance has lagged behind, suggesting a weaker position relative to the broader market. The stock's year-to-date performance shows a stark contrast, with a decline of 17.97% compared to the Sensex's gain of 6.02%. This underperformance in both short-term and year-to-date metrics highlights the challenges faced by Infinium Pharma in attracting investor interest amidst a generally positive market environment.